Anemia is not only a common problem in critically ill humans but also in TKand veterinary patients. Defined as an inability to carry adequate oxygen to the tissues of the body, anemia is caused by a ...

(RTTNews) - The U.S. Food and Drug Administration conditionally approved Elanco US Inc.'s Varenzin-CA1 (molidustat oral suspension) for treating anemia in cats with chronic kidney disease or CKD.

Elanco Launches Varenzin™-CA1 (molidustat oral suspension) – the First-of-its-Kind Oral Treatment for Anemia in Cats with Chronic Kidney Disease. September 07, 2023 04:15 PM Eastern Daylight Time.

Q: I have a darling 3-year-old female tabby cat named Sugar. She is my constant companion around the house since I work from home. She was spayed as a kitten ...

SILVER SPRING, Md. , May 1, 2023 /PRNewswire/ --Today, the U.S. Food and Drug Administration conditionally approved Varenzin-CA1 (molidustat oral suspension), the first drug for the control of ...

GREENFIELD, Ind.--(BUSINESS WIRE)-- Today, Elanco Animal Health Incorporated (NYSE: ELAN) announced that the first shipments of Varenzin™-CA1 (molidustat oral suspension), conditionally approved ...